Search Results 8881-8890 of 34135 for oral
... Oral and throat cancer, Laryngeal cancer, Skin tumor. Show more areas of focus for Katie M. Van Abel, M.D.. Research. Mayo Clinic doctors and scientists are ...
Prior oral tyrosine kinase inhibitors (i.e. sorafenib, pazopanib, regorafenib, cabozantanib) within 14 days of Cycle 1 Day 1. Other, prior systemic anti ...
Known GI disease or GI procedure that could interfere with the oral absorption or tolerance of ixazomib including difficulty swallowing. Diarrhea > Grade 1 ...
oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...
... oral medication. That swift delivery of the medication to the brain results in depression symptoms beginning to ease within several hours, and many people ...
Participants previously or currently treated with oral budesonide. Participants treated with endothelin (receptor) antagonists within 90 days prior to first ...
NOTE: Patients who have received acute, low-dose systemic steroids (≤ 10 mg/day oral prednisone or equivalent) prior to registration or a one-time pulse ...
Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...
The purpose of this study is to evaluate the impact of an extended oral TXA regimen on patient reported outcome scores, time to independent ambulation, ...
Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.